Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.26 -0.30 (-3.14%)
As of: Oct 1, 2026 · 3:59 PM EDT

Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024)

Updated

Xeris Biopharma Holdings' Tax Provisions came in at -$2.27 million for FY2024, compared with -$1.25 million in FY2023.

Analysis

Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024) Analysis & Trends

Going back to FY2020, Xeris Biopharma Holdings' Tax Provisions data covers 4 years.

  • Per Business Quant, earlier years put Tax Provisions at -$1.25 million in FY2023, -$1.42 million in FY2022 and -$110,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Xeris Biopharma Holdings 1.66 Bn 1.22 Bn 79.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -3.32 Mn
Jun 30, 2024 749,000.00
Mar 31, 2024 307,000.00
Dec 31, 2023 -236,000.00
Sep 30, 2023 -338,000.00
Jun 30, 2023 -675,000.00
Dec 31, 2022 -338,000.00
Sep 30, 2022 -339,000.00
Jun 30, 2022 -339,000.00
Mar 31, 2022 -408,000.00
API Access

Xeris Biopharma Holdings Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=XERS&period=max&api_key=YOUR_API_KEY